Table II.

Association between TAFA5 expression and clinicopathological variables in gastric cancer (n=90).

		TAFA5 expression
Clinicopathological feature	Number of patients	Low (41)	High (49)	P-value
Sex
Male	69	32 (46.4)	37 (53.6)
Female	21	9 (42.9)	12 (57.1)	0.488
Age
<70	45	22 (48.9)	23 (51.1)
≥70	45	19 (42.2)	26 (57.8)	0.336
Histological grade
G2	28	18 (64.3)	10 (35.7)
G3	62	23 (37.1)	39 (62.9)	0.015
Tumor size (cm)
<5	35	18 (51.4)	17 (48.6)
≥5	54	22 (40.7)	32 (59.3)	0.220
Tumor stage
T1/T2	20	17 (85.0)	3 (15.0)
T3/T4	70	24 (34.3)	46 (65.7)	0.001
Nodal stage
N0	24	16 (66.7)	8 (33.3)
N1-N3	66	25 (37.9)	41 (62.1)	0.014
TNM stage
I/II	38	24 (63.2)	14 (36.8)
III/IV	52	17 (32.7)	35 (67.3)	0.004
Vessel invasion
No	74	34 (45.9)	40 (54.1)
Yes	16	7 (43.8)	9 (56.2)	0.548
Nerve invasion
No	74	35 (47.3)	39 (52.7)
Yes	15	6 (40.0)	9 (60.0)	0.410

Bold type indicates significance.